Biology Reference
In-Depth Information
Pastorino S, Massazza S, Cilli M, Varesio L, Bosco MC (2001) Generation of high-titer
retroviral vector-producing macrophages as vehicles for in vivo gene transfer. Gene Ther
8:431-441
Poppe H, Rybalkin SD, Rehmann H, Hinds TR, Tang X-B, Christensen AE, Schwede F, Genieser
H-G, Bos JL, Doskeland SO, Beavo JA, Butt E (2008) Cyclic nucleotide analogs as probes of
signaling pathways. Nat Meth 5:277-278
Ransj
o M, Lie A, Mackie EJ (1999) Cholera toxin and forskolin stimulate formation of osteoclast-
like cells in mouse marrow cultures and cultured mouse calvarial bones. Eur J Oral Sci
107:45-54
Reneland R, Mah S, Kammerer S, Hoyal C, Marnellos G, Wilson S, Sambrook P, Spector T,
Nelson M, Braun A (2005) Association between a variation in the phosphodiesterase 4D gene
and bone mineral density. BMC Med Genet 6:9
Scandella E, Men Y, Gillessen S, Forster R, Groettrup M (2002) Prostaglandin E2 is a key factor
for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood
100:1354-1361
Shayo C, Davio C, Brodsky A, Mladovan AG, Legnazzi BL, Rivera E, Baldi A (1997) Histamine
modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the
human promonocytic cell line U937. Mol Pharmacol 51:983-990
Shayo C, Fernandez N, Legnazzi BL, Monczor F, Mladovan A, Baldi A, Davio C (2001)
Histamine H2 receptor desensitization: involvement of a select array of G protein-coupled
receptor kinases. Mol Pharmacol 60:1049-1056
Shayo C, Legnazzi BL, Monczor F, Fern
´
ndez N, Riveiro ME, Baldi A, Davio C (2004) The time-
course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation. Biochem
Biophys Res Comm 314:798-804
Shepherd MC, Baillie GS, Stirling DI, Houslay MD (2004) Remodelling of the PDE4 cAMP
phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937
cells. Br J Pharmacol 142:339-351
Spina D (2008) PDE4 inhibitors: current status. Br J Pharmacol 155:308-315
Takami M, Cho ES, Lee SY, Kamijo R, Yim M (2005) Phosphodiesterase inhibitors stimulate
osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of
ERK and p38 MAPK pathways. FEBS Lett 579:832-838
Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S,
Udagawa N, Takahashi N (2005) Prostaglandin E2 strongly inhibits human osteoclast forma-
tion. Endocrinology 146:5204-5214
Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL (2002) 8-Isoprostaglandin
E2 enhances receptor-activated NFkB ligand (RANKL)-dependent osteoclastic potential of
marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277:14221-14226
Torphy TJ, Zhou HL, Cieslinski LB (1992) Stimulation of beta adrenoceptors in a human
monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
J Pharmacol Exp Ther 263:1195-1205
Tortora G, Clair T, Cho-Chung YS (1990) An antisense oligodeoxynucleotide targeted against the
type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation
in HL-60 leukemia cells without affecting phorbol ester effects. Proc Natl Acad Sci USA
87:705-708
Tortora G, Yokozaki H, Pepe S, Clair T, Cho-Chung YS (1991) Differentiation of HL-60 leukemia
by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein
kinase. Proc Natl Acad Sci USA 88:2011-2015
Tudhope SJ, Finney-Hayward TK, Nicholson AG, Mayer RJ, Barnette MS, Barnes PJ, Donnelly
LE (2008) Different mitogen-activated protein kinase-dependent cytokine responses in cells of
the monocyte lineage. J Pharmacol Exp Ther 324:306-312
Vairo G, Argyriou S, Bordun AM, Whitty G, Hamilton JA (1990) Inhibition of the signaling
pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to
colony stimulating factor-1. J Biol Chem 265:2692-2701
€
